WAVE — Waverley Pharma Balance Sheet
0.000.00%
Last trade - 00:00- CA$0.81m
- CA$3.97m
- CA$0.48m
- 25
- 70
- 40
- 42
Annual balance sheet for Waverley Pharma, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.71 | 0.158 | 0.134 | 0.053 | 0.236 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.456 | 0.702 | 0.193 | 0.138 | 0.209 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 1.68 | 1.45 | 0.633 | 0.417 | 0.73 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | — | — | — | 0.263 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 3.49 | 3.68 | 2.69 | 0.952 | 2.05 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.41 | 1.89 | 1.6 | 2.09 | 3.86 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 1.45 | 1.89 | 1.6 | 2.09 | 4.08 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 2.04 | 1.79 | 1.09 | -1.14 | -2.03 |
| Total Liabilities & Shareholders' Equity | 3.49 | 3.68 | 2.69 | 0.952 | 2.05 |
| Total Common Shares Outstanding |